During this segment, Dennis Patrick Scanlon, PhD, invites the panelists to discuss whether a common ground can be achieved between state-run Medicaid agencies and private employer-run programs, with respect to value-based purchasing.
Francois de Brantes, MS, MBA, emphasizes a need for aggressive management of healthcare costs, pointing to several innovative state-run programs. These programs, says Mr de Brantes, have increased resident tax rates and have resulted in push-back. “The state government will have to find a way to react to that,” he adds.
As for private payers following the Medicare lead, Arthur Vercillo, MD, FACS, indicates that innovative private payer plans are often met with skepticism. Private payers introducing a new policy are often questioned by providers on CMS recommendations said Dr Vercillo; there is wider acceptance if the program comes directly from CMS instead of the private payer. Ateev Mehrotra, MD, MPH, agreed that it is difficult to do what Medicare—a dominant payer in many services—does.
Indicating that there is more innovation in the private sector, Dr Vercillo thinks that the Affordable Care Act will allow for increased collaboration among stakeholders.
Dr Scanlon asks the panelists the provider perception of these programs and whether they feel threatened that their practice may not meet the value standards. “Do providers need to change the way in which they practice to extract greater value?” he asks.
With an anecdote, Dr Vercillo suggests that all parties including patients, provides, and payers, have to work together. He goes on to emphasize the value of measuring data and comparing it to benchmarked standards and data from other providers to evaluate performance.
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More